Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorPak Emirates Military Hospital
About this trial
To determine the effectiveness of prophylactic intravenous calcium chloride administered after cord clamping in reducing postpartum blood loss during intrapartum cesarean section.
Eligibility criteria
Qualifiers
Women aged 18-45 years undergoing intrapartum cesarean section at ≥34 weeks of gestation.
Exposure to oxytocin during labor before CS.
Singleton pregnancy with no known fetal anomalies.
Disqualifiers
Known bleeding disorders or preoperative coagulation abnormalities
Preeclampsia or hypertensive disorders contraindicate calcium use.
History of cardiac disease or arrhythmias
Placental abnormalities, i.e., placenta previa, accreta
Trial design
Treatments tested in this trial
- Calcium Chloride
- Placebo
Treatment groups
182 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov